Purchase Order 19GE5023P0128
Award Date 9/20/23
Potential Completion Date 11/20/23
Potential Value $53K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Thailand
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Economy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price purchase order was awarded to Bio-Active Company LIMITED, a for-profit limited liability company, to provide Illumina reagents on behalf of the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand. The $27,544.10 contract was issued by the U.S. Department of the Army and has a period of performance ending on September 30, 2024. Bio-Active Company LIMITED has a history of delivering genetic sequencing systems, reagents, and testing materials to...
- The Department of the Army awarded a purchase order to Bio-Active Company LIMITED for $50,369.03 on September 8, 2025, for procurement of Illumina sequencing platforms (MiSeq and NextSeq) to support DNA and RNA sequencing of clinical, environmental, and vector-borne disease samples. Performance occurs in Bangkok, Thailand, with completion by September 7, 2026. The order is firm fixed price with no small business set-aside. The equipment and associated support serve the Armed Forces Research...
- This is a firm-fixed-price purchase order awarded by the Defense Health Agency, a component of the U.S. Department of Defense, to Bio-Active Company LIMITED, a for-profit limited liability company located in Thailand. The $112,739.29 contract is for the purchase of an Illumina MiSeq genetic sequencing system, including reagents and associated components. This award is not associated with a larger contract vehicle, and no small business set-aside provisions were used. Bio-Active Company LIMITED...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency, a defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The contract is for the acquisition of MISEQI100PLUS systems on behalf of the Armed Forces Research Institute of Medical Sciences (AFRIMS) Thailand. The contract has a ceiling value of $174,099.88 and an ultimate completion date of November 30, 2025. No small business set-aside was used for this...
- This is a firm fixed price contract awarded to Bio-Active Company LIMITED, a for-profit limited liability company, by the U.S. Department of Defense's Medical Command (MEDCOM). The contract provides for services related to the operation and maintenance of Illumina MiSeq genetic sequencing systems used to support infectious disease monitoring and research in Thailand. The award, valued at $27,615.93, is a call against a previously established Blanket Purchase Agreement between Bio-Active...
- This is a firm fixed price purchase order awarded by the Chief of Naval Operations (CNO), a Defense agency, to Bio-Active Company LIMITED, a for-profit limited liability company. The contract is to provide Illumina sequencing systems, reagents, and testing materials to support infectious disease monitoring and research conducted by the U.S. government in Thailand. The total ceiling value of the purchase order is $35,043.75, and the period of performance runs through May 2, 2023. This award...
- The Department of the Army awarded a $15,432 purchase order to Miscellaneous Foreign Awardees for the acquisition of reagents and medical supplies on behalf of the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Thailand. The firm fixed price contract runs from September 15, 2023 through November 30, 2023 and will deliver the requested products to support AFRIMS, a biomedical research laboratory of the U.S. military that conducts research on infectious diseases prevalent in...
- This is a firm fixed price purchase order awarded by the Department of Defense, Bureau of Medicine and Surgery, to Bio-Active Company LIMITED, a for-profit limited liability company in Thailand. The $96,091.00 contract is for preventive maintenance on an Illumina MiSeq genetic sequencing system. This purchase order is not associated with a larger contract vehicle, and no set-aside designation was used. Based on Bio-Active Company LIMITED's past awards for biomedical goods and services to support...
- This is a firm fixed price contract awarded by the Office of the Secretary of Defense to Bio-Active Company LIMITED, a for-profit limited liability company, to provide maintenance and emergency services for an Illumina MiSeq genetic sequencing instrument located in Thailand. The contract, valued at $29,088.00, is a call against a pre-existing Blanket Purchase Agreement to support infectious disease monitoring and research efforts by various U.S. government agencies, including the Centers for...
- This is a firm fixed price purchase order awarded by the U.S. Department of Defense's Bureau of Medicine and Surgery (BUMED) to Bio-Active Company Limited, a for-profit limited liability company based in Thailand. The contract, valued at $81,605.50, is for preventive maintenance services on an Illumina MiSeq genetic sequencing system located at the U.S. Naval Medical Research Unit-2 (NAMRU-2) facility in Cambodia. The contract was competitively awarded and does not have a set-aside...